Literature DB >> 31444480

MENTOR heralds a new era of therapy for membranous nephropathy.

Aikaterini Nikolopoulou1, Megan Griffith2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 31444480     DOI： 10.1038/s41581-019-0200-1

Source DB:  PubMed          Journal:  Nat Rev Nephrol        ISSN： 1759-5061            Impact factor:   28.314


× No keyword cloud information.
  1 in total

1.  Effect of belimumab on proteinuria and anti-phospholipase A2 receptor autoantibody in primary membranous nephropathy.

Authors:  Christine Barrett; Lisa C Willcocks; Rachel B Jones; Ruth M Tarzi; Robert B Henderson; Gengqian Cai; Sophie I Gisbert; Alexandra S Belson; Caroline O Savage
Journal:  Nephrol Dial Transplant       Date:  2020-04-01       Impact factor: 5.992
  1 in total
  1 in total

1.  Rituximab Therapy for Primary Membranous Nephropathy in a Chinese Cohort.

Authors:  Shuang Gao; Zhao Cui; Xin Wang; Yi-Miao Zhang; Fang Wang; Xu-Yang Cheng; Li-Qiang Meng; Fu-de Zhou; Gang Liu; Ming-Hui Zhao
Journal:  Front Med (Lausanne)       Date:  2021-05-20
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.